BioNova Member IMV Inc. will begin the first round of human trials for their COVID-19 vaccine this summer. The Maritime lab had a head start in the vaccine development process, building on a vaccine it developed to combat a different respiratory illness.
- Outcast Foods & Greenhouse Partner for a Zero Waste Future
- T4G Acquired by National Firm MNP
- Health Canada Clears Appili Therapeutics’ Phase 2 Clinical Trial Evaluating Favipiravir as a Prophylactic Agent Against COVID-19 Outbreaks
- Sona Nanotech Finalizing Submission to Health Canada and FDA for the Fastest COVID-19 Test kit
- Interview with Mo Abdolel, CEO & Founder, Densitas Inc